Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

Alterity Therapeutics Ltd

ASX:ATH

Alterity Therapeutics is a late-clinical stage biotechnology company dedicated to developing treatments for people living with neurodegenerative diseases. The company is initially focused on developing disease modifying therapies in Parkinson’s disease and related disorders. 

1 story